Epidemiology and Evaluation Department, Hospital del Mar, Barcelona, Spain; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; REDISSEC (Health Services Research on Chronic Patients Network), Madrid, Spain.
Epidemiology and Evaluation Department, Hospital del Mar, Barcelona, Spain; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; REDISSEC (Health Services Research on Chronic Patients Network), Madrid, Spain.
Eur J Cancer. 2019 Jan;107:53-59. doi: 10.1016/j.ejca.2018.11.004. Epub 2018 Dec 10.
Increased values in the fecal immunochemical test (FIT) are correlated with increasingly severe colorectal neoplasia, but little attention has been given to FIT values below the cut-off point (negative FIT, nFIT). We analysed the relationship between the concentrations of two consecutive nFIT and the risk of following screen-detected advanced neoplasia and interval cancer (IC) in a population-based colorectal cancer screening program.
FIT results were categorised into non-detectable nFIT (0-3.8 μg haemoglobin/g feces), low nFIT (3.9-9.9) and high nFIT (10.0-19.9). Multivariable adjusted logistic regression was used to estimate the odds ratios (OR) of advanced neoplasia and IC with the nFIT results in the first two screens.
More than 90% of the 42,524 persons had non-detectable nFIT in the first and second screen; 4.5% and 5.8% had a low nFIT, respectively, and 2.2% and 2.9% had a high nFIT. The probability of testing positive and being diagnosed of advanced neoplasia or IC rose with increasing values of nFIT. Compared with those with two non-detectable nFIT results, the highest OR were found among those who had two high nFIT results (OR 21.75; 95% confidence interval: 12.44, 38.04) and those with one low nFIT and one high nFIT (ORs around 20).
Participants with nFIT results above the detection limit of the test had an increased risk of advanced neoplasia and IC in subsequent participations. This information could be used in the design of personalised screening strategies.
粪便免疫化学检测(FIT)值升高与结直肠肿瘤的严重程度呈正相关,但很少关注检测值低于临界值(阴性 FIT,nFIT)的情况。我们分析了人群结直肠癌筛查项目中连续两次 nFIT 值与随后筛查出的高级别肿瘤和间期癌(IC)风险之间的关系。
将 FIT 结果分为不可检测的 nFIT(0-3.8μg 血红蛋白/g 粪便)、低 nFIT(3.9-9.9)和高 nFIT(10.0-19.9)。使用多变量调整的逻辑回归来估计前两次筛查中 nFIT 结果与高级别肿瘤和 IC 的比值比(OR)。
超过 90%的 42524 人在第一次和第二次筛查中均未检出 nFIT;分别有 4.5%和 5.8%的人低 nFIT,2.2%和 2.9%的人高 nFIT。随着 nFIT 值的增加,检测阳性和诊断高级别肿瘤或 IC 的概率也随之增加。与两次 nFIT 结果均为阴性的人相比,两次 nFIT 结果均为阳性的人(OR 21.75;95%置信区间:12.44,38.04)和一次 nFIT 结果为阴性和一次 nFIT 结果为阳性的人(OR 值约为 20)的最高 OR 最高。
nFIT 值高于检测限的参与者在后续参与中发生高级别肿瘤和 IC 的风险增加。这些信息可用于设计个性化的筛查策略。